Global Gastrointestinal Cancer Drugs Market Research Report 2017
Published On: October 2017
 
Report ID:155987
 
 
Pages: 109




In this report, the global Gastrointestinal Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Cancer Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Gastrointestinal Cancer Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
F. Hoffmann-La Roche
Eli Lilly and Company
Johnson & Johnson Private Limited
GlaxoSmithKline
Celgene Corporation
Pfizer
Sanofi
Novartis
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immunotherapy
Chemotherapy
Targeted Therapy
Hormone Therapy
Adjuvant Chemotherapy
Radiation Therapy
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Gastrointestinal Cancer Drugs for each application, including
Hospitals
Specialized Cancer Treatment Centers
Clinics
Ambulatory Surgical Centers
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Gastrointestinal Cancer Drugs Market Research Report 2017
1 Gastrointestinal Cancer Drugs Market Overview
1.1 Product Overview and Scope of Gastrointestinal Cancer Drugs
1.2 Gastrointestinal Cancer Drugs Segment by Type (Product Category)
1.2.1 Global Gastrointestinal Cancer Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Gastrointestinal Cancer Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Targeted Therapy
1.2.6 Hormone Therapy
1.2.7 Adjuvant Chemotherapy
1.2.8 Radiation Therapy
1.2.9 Others
1.3 Global Gastrointestinal Cancer Drugs Segment by Application
1.3.1 Gastrointestinal Cancer Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Specialized Cancer Treatment Centers
1.3.4 Clinics
1.3.5 Ambulatory Surgical Centers
1.4 Global Gastrointestinal Cancer Drugs Market by Region (2012-2022)
1.4.1 Global Gastrointestinal Cancer Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Gastrointestinal Cancer Drugs (2012-2022)
1.5.1 Global Gastrointestinal Cancer Drugs Revenue Status and Outlook (2012-2022)
1.5.2 Global Gastrointestinal Cancer Drugs Capacity, Production Status and Outlook (2012-2022)
2 Global Gastrointestinal Cancer Drugs Market Competition by Manufacturers
2.1 Global Gastrointestinal Cancer Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Gastrointestinal Cancer Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Gastrointestinal Cancer Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Gastrointestinal Cancer Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Gastrointestinal Cancer Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Gastrointestinal Cancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Gastrointestinal Cancer Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal Cancer Drugs Market Concentration Rate
2.5.2 Gastrointestinal Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Gastrointestinal Cancer Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Gastrointestinal Cancer Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Gastrointestinal Cancer Drugs Production and Market Share by Region (2012-2017)
3.3 Global Gastrointestinal Cancer Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Gastrointestinal Cancer Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Gastrointestinal Cancer Drugs Consumption by Region (2012-2017)
4.2 North America Gastrointestinal Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Gastrointestinal Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Gastrointestinal Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Gastrointestinal Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Gastrointestinal Cancer Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Gastrointestinal Cancer Drugs Production, Consumption, Export, Import (2012-2017)
5 Global Gastrointestinal Cancer Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Gastrointestinal Cancer Drugs Production and Market Share by Type (2012-2017)
5.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Gastrointestinal Cancer Drugs Price by Type (2012-2017)
5.4 Global Gastrointestinal Cancer Drugs Production Growth by Type (2012-2017)
6 Global Gastrointestinal Cancer Drugs Market Analysis by Application
6.1 Global Gastrointestinal Cancer Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Gastrointestinal Cancer Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Gastrointestinal Cancer Drugs Manufacturers Profiles/Analysis
7.1 Amgen Limited & Amgen Ireland Limited
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Bristol-Myers Squibb Company
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 F. Hoffmann-La Roche
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 F. Hoffmann-La Roche Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Eli Lilly and Company
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Johnson & Johnson Private Limited
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Celgene Corporation
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Pfizer
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Pfizer Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Sanofi
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Sanofi Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Novartis
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Novartis Gastrointestinal Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
8 Gastrointestinal Cancer Drugs Manufacturing Cost Analysis
8.1 Gastrointestinal Cancer Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Gastrointestinal Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gastrointestinal Cancer Drugs Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Gastrointestinal Cancer Drugs Market Forecast (2017-2022)
12.1 Global Gastrointestinal Cancer Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Gastrointestinal Cancer Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Gastrointestinal Cancer Drugs Price and Trend Forecast (2017-2022)
12.2 Global Gastrointestinal Cancer Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Gastrointestinal Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Gastrointestinal Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Gastrointestinal Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Gastrointestinal Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Gastrointestinal Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Gastrointestinal Cancer Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Gastrointestinal Cancer Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Gastrointestinal Cancer Drugs Consumption Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer





Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.